Patent 11213482 was granted and assigned to University of Pittsburgh on January, 2022 by the United States Patent and Trademark Office.
A recombinant coronavirus vaccine is provided. Methods of making and delivering the coronavirus vaccine also are provided. A microneedle array is provided, along with methods of making and using the microneedle array.